Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
New England Journal of Medicine.
Times cited: 403
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.
Journal of Acquired Immune Deficiency Syndromes.
Times cited: 27